Ascendis Pharma A/S (ASND) vs Halozyme Therapeutics, Inc. (HALO)
- Ascendis Pharma A/S ASND 225.78 −0.37%
- Halozyme Therapeutics, Inc. HALO 121.84 +0.27%
Ascendis Pharma A/S and Halozyme Therapeutics, Inc. are both Biotechnology companies. Ascendis Pharma A/S and Halozyme Therapeutics, Inc. are of similar size ($14.9B and $13.8B). Ascendis Pharma A/S trades at the lower P/E: 16.3× against 34.6×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against 41.2%. Ascendis Pharma A/S has the higher net margin (71.2% vs 24.9%) and the lower return on invested capital (15.1% vs 18.1%). Across the 22 metrics below, Ascendis Pharma A/S leads on 12 and Halozyme Therapeutics, Inc. on 10.
Valuation
Profitability
| Metric | ASND | HALO | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.26% | 82.42% | 65.16% |
| Operating margin | 24.84% | 35.90% | 0.00% |
| Net margin | 71.20% | 24.86% | 0.00% |
| Free cash flow margin | 31.97% | 48.46% | 0.00% |
| Return on equity | 118.44% | 173.67% | (56.36%) |
| Return on assets | 44.34% | 17.86% | (48.04%) |
| Return on invested capital | 15.07% | 18.13% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack